SCOTUS Fells MD Price-Gouging Law; New Bill Could Be Vulnerable

By Rachel Cohrs / February 19, 2019 at 5:22 PM
In a win for generic drug makers, the Supreme Court on Tuesday (Feb. 19) left in place a lower court ruling that struck a Maryland law against generic drug price gouging. A separate, popular Maryland bill to establish a drug-payment-setting board also is vulnerable to legal challenges, though the legal argument used to strike the generic price-gouging law likely would not apply, according to documents obtained by Inside Health Policy . Maryland passed a law in 2017 to let...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.